Macular Degeneration

Showing NaN - NaN of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

Recruiting
  • Macular Degeneration
  • Geographic Atrophy
  • Phoenix, Arizona
  • +83 more
Aug 19, 2022

Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

Completed
  • Age-Related Maculopathy
  • +4 more
  • RN6G
  • Placebo
  • Campbell, California
  • +23 more
May 10, 2022

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Completed
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +77 more
Mar 17, 2022

Macular Degeneration Trial in Worldwide (Ranibizumab)

Completed
  • Macular Degeneration
  • Ranibizumab
  • Gilbert, Arizona
  • +101 more
Mar 11, 2022

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Active, not recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Beverly Hills, California
  • +208 more
Sep 14, 2021

Macular Degeneration Trial in United States (Ranibizumab)

Completed
  • Macular Degeneration
  • Mesa, Arizona
  • +49 more
Apr 12, 2021

Macular Degeneration Trial in United States (Abicipar pegol)

Completed
  • Macular Degeneration
  • Abicipar pegol
  • Phoenix, Arizona
  • +36 more
Jul 17, 2020

Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

Completed
  • Macular Degeneration
  • Abicipar Pegol
  • +2 more
  • Birmingham, Alabama
  • +186 more
Jul 17, 2020

Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

Completed
  • Macular Degeneration
  • Abicipar Pegol
  • +2 more
  • Phoenix, Arizona
  • +150 more
Jul 16, 2020

Retinal Drusen, Age-related Macular Degeneration, Macular Degeneration Trial in Austin (Lumega-Z, AREDS2)

Completed
  • Retinal Drusen
  • +2 more
  • Lumega-Z
  • AREDS2
  • Austin, Texas
    Eye Clinic of Austin
May 9, 2019

Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)

Terminated
  • Geographic Atrophy
  • Macular Degeneration
  • 400 µg Brimonidine Implant
  • Sham
  • Phoenix, Arizona
  • +40 more
Mar 29, 2019

Macular Degeneration Trial in Worldwide (pazopanib eye drops, , ranibizumab intravitreal injection)

Completed
  • Macular Degeneration
  • pazopanib eye drops
  • +2 more
  • Peoria, Arizona
  • +76 more
Dec 7, 2017

Macular Degeneration Trial in Worldwide (Pazopanib)

Completed
  • Macular Degeneration
  • Tucson, Arizona
  • +26 more
Oct 18, 2017

Macular Degeneration Trial in Minneapolis, Austin, Tacoma (GW786034, Placebo)

Completed
  • Macular Degeneration
  • Minneapolis, Minnesota
  • +2 more
Nov 10, 2017

Macular Degeneration Trial in United States (Pazopanib)

Completed
  • Macular Degeneration
  • Beverly Hills, California
  • +6 more
Nov 7, 2017

Macular Degeneration Trial in France, Germany, United States (pazopanib eye drops)

Terminated
  • Macular Degeneration
  • pazopanib eye drops
  • Phoenix, Arizona
  • +14 more
Aug 23, 2017

Macular Degeneration Trial in Worldwide (Regorafenib, ophthalmic oily suspension (BAY73-4506), Sham IVT, Ranibizumab)

Terminated
  • Macular Degeneration
  • Regorafenib, ophthalmic oily suspension (BAY73-4506)
  • +3 more
  • Tucson, Arizona
  • +148 more
Jul 25, 2016

Macular Degeneration, Choroidal Neovascularization Trial in Austin (Verteporfin photodynamic therapy, Pegaptanib, Triamcinolone

Completed
  • Macular Degeneration
  • Choroidal Neovascularization
  • Verteporfin photodynamic therapy
  • +2 more
  • Austin, Texas
    Novartis Investigational Site
Mar 3, 2016

Macular Degeneration Trial in Worldwide (rhuFab V2 (ranibizumab))

Completed
  • Macular Degeneration
  • rhuFab V2 (ranibizumab)
  • Tucson, Arizona
  • +81 more
Mar 18, 2014

Macular Degeneration Trial in United States (VEGF Trap Eye)

Completed
  • Macular Degeneration
  • VEGF Trap Eye
  • Peoria, Arizona
  • +32 more
Jun 10, 2013

Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))

Completed
  • Macular Degeneration
  • ranibizumab
  • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
  • Birmingham, Alabama
  • +187 more
Dec 20, 2012

Macular Degeneration, Age-related Macular Degeneration Trial in Fargo, Austin (Pazopanib eye drops and Allergen Refresh Plus eye

Completed
  • Macular Degeneration
  • Age-related Macular Degeneration
  • Pazopanib eye drops and Allergen Refresh Plus eye drops
  • Fargo, North Dakota
  • +1 more
Mar 15, 2012

Macular Degeneration Trial in Worldwide (Epi-Rad90™ Ophthalmic System, ranibizumab)

Unknown status
  • Macular Degeneration
  • Phoenix, Arizona
  • +31 more
Jul 26, 2011

Macular Degeneration, Choroidal Neovascularization Trial in Canada, United States (Verteporfin Photodynamic Therapy,

Completed
  • Macular Degeneration
  • Choroidal Neovascularization
  • Verteporfin Photodynamic Therapy
  • +3 more
  • Tucson, Arizona
  • +42 more
Mar 23, 2011